Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests. They ...

Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation ...

Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutationPhase 2 results ...

Based on initial positive results from HOPE-B, etranacogene dezaparvovec became the first gene therapy approved for adults ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

Whether you turn red when drinking alcohol, dislike certain smells, or metabolize drugs differently from others, the explanation often ...

New research published in Brain, Behavior, and Immunity provides evidence that alcohol use disorder triggers a distinct type ...

The US regulator has approved Waskyra (etuvetidigene autotemcel), the first gene-correcting therapy for Wiskott-Aldrich ...

The developmental period is a critical window during which environmental cues interact with the genome to shape lifelong trajectories of health and disease.

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...